-
Posted by
Two Blokes Apr 22 -
Filed in
Stock
-
4 views
Swiss pharma giant Roche said it will invest US$50 billion into the US in the next five years to ensure it exports more medicines from the country than it imports, amid threats of potential tariffs on the sector from President Donald Trump. The Basel-headquartered group said it will expand and upgrade US manufacturing and distribution capabilities for its medicines and diagnostics tests in Kentucky, Indiana, New Jersey, Oregon and California, where it Other planned investments were flagged, including new manufacturing facilities for gene therapy in Pennsylvania and continuous glucose monitoring in Indiana, with a new manufacturing centre for its weightloss medicines in a location to be announced.
